JFJohn W. Fabre

John W. Fabre

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


John W. Fabre has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A proposal for better governance of the NHS at a national level

    by John Fabre

    The NHS is now widely regarded to be in crisis. Campaigners and politicians usually see more funding as the key to rescuing the NHS from its current straits. However, while money is an important part of any solution, it is not the key issue. Simply pouring money into the existing structure provides inefficient, short-term and piecemeal solutions. A key issue is that there is little effective national governance and no mechanism for reaching a consensus on the many bitter controversies and critical problems afflicting the NHS. Addressing these issues is an essential first step, and a matter of urgency.

  • Open Access

    Presumed consent for organ donation: a clinically unnecessary and corrupting influence in medicine and politics

    by John Fabre

    Presumed consent is a legislative framework in which citizens must place their name on a national opt-out register, otherwise their consent for donating their organs will be presumed. The Welsh Assembly last year passed legislation to enable the introduction of presumed consent in Wales in 2015. The issue is currently being discussed in Northern Ireland, Scotland and the Republic of Ireland. However, there is scant evidence that presumed consent will be effective. Rather than legislating for consent of donors, we should be addressing the misgivings and misunderstandings of families to improve their consent rate, as has been done so successfully in Spain. National improvements in infrastructure in the UK have resulted in an outstanding 63% increase in deceased donation since 2007. If, now, family consent rates could be improved from the current 57% to Spanish levels of 85%, the UK's donation rate would be one of the best in the world.


  • In vivo studies on non-viral transdifferentiation of liver cells towards pancreatic β cells

    by Abdullah Cim, Greta J Sawyer, Xiaohong Zhang, Haibin Su, Louise Collins, Peter Jones, Michael Antoniou, Jean-Paul Reynes, Hans-Joachim Lipps, John W Fabre

    Transdifferentiationin vivois an attractive option for autologous replacement of pancreatic β cells in patients with type 1 diabetes. It has been achieved by adenoviral delivery of genes for transcription factors in the liver and pancreas of hyperglycaemic mice. However, these viral approaches are not clinically applicable. We used the hydrodynamic approach to deliver genesPdx1,Ngn3(Neurog3) andMafAsingly and in combination to livers of normoglycaemic rats. Five expression plasmids were evaluated. Livers were removed 1, 3, 7, 14 and 28 days after gene delivery and assayed by quantitative PCR, semi-quantitative PCR and immunohistology. Functional studies on hyperglycaemic rats were performed. The highest and most sustained expression was from a CpG-depleted plasmid (pCpG) and a plasmid with an in-frame scaffold/matrix attachment region ((pEPI(CMV)). WhenPdx1,Ngn3andMafAwere delivered together to normoglycaemic rats with these plasmids, insulin mRNA was detected at all time points and was ∼50-fold higher with pCpG. Insulin mRNA content of livers at days 3 and 7 was equivalent to that of a pancreas, with scattered insulin-positive cells detected by immunohistology, but levels declined thereafter. Prohormone convertase 1/3 was elevated at days 3 and 7. In hyperglycaemic rats, fasting blood glucose was lower at days 1, 3 and 7 but not thereafter, and body weight was maintained to day 28. We conclude that hydrodynamic gene delivery of multiple transcription factors to rat liver can initiate transdifferentiation to pancreatic β cells, but the process is reversible and probably requires more sustained transcription factor expression.


  • Critical Physiological and Surgical Considerations for Hydrodynamic Pressurization of Individual Segments of the Pig Liver

    by John W. Fabre, Michael Whitehorne, Aidan Grehan, Greta J. Sawyer, Xiaohong Zhang, Mark Davenport, Mohamed Rela

    Hydrodynamic gene delivery to the liver is a promising approach for liver gene therapy in the clinic, but levels of gene expression in larger species have been much less than in rodents. The development of surgical techniques for pressurizing individual liver segments and the establishment of whether hepatic vascular anatomy in fact permits pressurization of individual segments are critical issues that need to be addressed. We have evaluated these issues using hydrodynamic delivery to individual segments of the pig liver, via branches of both portal and hepatic veins. Our objective was to develop surgical techniques that achieve elevated vascular pressures within individual liver segments with small volumes, but without interruption of portal blood flow or reduction in venous return to the heart. We report that, without specific surgical interventions to obstruct outflow of DNA solution from the targeted liver segment, little or no increase in intrahepatic vascular pressure occurs. We demonstrate, for the first time, that selective pressurization of individual liver segments is possible without compromising portal venous flow or venous return to the heart. Thus, hydrodynamic gene delivery to individual liver segments is technically achievable in a clinical setting, but will require open abdominal surgery rather than minimally invasive techniques. In this methods article, Fabre and colleagues report on a preclinical large animal model, examining the practicality of regional hydrodynamic gene delivery to the pig liver and using branches of both portal and hepatic veins for DNA delivery.


  • Presumed consent: a distraction in the quest for increasing rates of organ donation

    by John Fabre, Paul Murphy, Rafael Matesanz

    Spain has the highest rate of organ donation in the world and is often cited as a successful example of presumed consent legislation. However, the country does not have an opt-out register, nor is public awareness of the 1979 legislation promoted. John Fabre, Paul Murphy, and Rafael Matesanz argue that the presumed consent legislation is dormant, and that Spain in fact demonstrates it is possible to have the highest rates of organ donation without recourse to presumed consent


  • Self-Assembly of Peptides into Spherical Nanoparticles for Delivery of Hydrophilic Moieties to the Cytosol

    by Louise Collins, Alan L. Parker, John D. Gehman, Lorna Eckley, Matthew A. Perugini, Frances Separovic, John W. Fabre

    We report a novel class of self-assembling peptide nanoparticles formed by mixing aqueous solutions of K16 peptide and a 20 amino acid peptide of net charge −5 (GLFEALLELLESLWELLLEA). Particle formation is salt-dependent and yields perfectly spherical nanoparticles of ∼120 to ∼800 nm diameter, depending on buffer composition and temperature, with a stoichiometry of ∼1:2.5 for the cationic and anionic peptides. The anionic peptide forms an α-helix in aqueous solution, has all five glutamates on one side of the helix, and exists entirely as a discrete oligomer of 9−10 peptides. A rigid oligomer with 45−50 negative charges almost certainly represents the core component of these nanoparticles, held together by electrostatic interactions with the unstructured K16 peptide. Cells internalize these particles by an endocytic process, and free particles are frequently seen in the cytosol, presumably because of the acid-dependent fusogenic properties of the anionic peptide. Among other applications, these particles have potential for the targeted delivery of single or multiple therapeutic moieties directly to the cytosol, and we report the successful delivery of a K16-linked pro-apoptosis peptide.


  • Open Access

    Fatherhood and medicine

    by John Fabre

    Having children will inevitably, to a greater or lesser degree, have a negative impact on a woman doctor's career progression. It is a major challenge to create a working environment which optimises her career progression, and at the same time enables optimal parental care for her children. This is a multi-faceted issue, but the quality of childcare is rarely discussed, except in terms of nursery places and tax deductions. The perspective of the father, and his potential contribution to the sustenance of his wife's career and the welfare of his children, are rarely considered. The woman doctor's perspective as a mother is also put to one side. The major burden of childcare for the foreseeable future will fall on the mother, but the key issue (for parents and administrators) is that the period of intensive childcare is limited and, once complete, both careers can proceed at full pace.

  • Low-volume hydrodynamic gene delivery to the rat liver via an isolated segment of the inferior vena cava: efficiency, cardiovascular response and intrahepatic vascular dynamics

    by Greta J. Sawyer, Aidan Grehan, Xuebin Dong, Michael Whitehorne, Michael Seddon, Ajay M. Shah, Xiaohong Zhang, Siamak Salehi, John W. Fabre

    Background Clinical application of hydrodynamic gene delivery to the liver requires the use of small volumes, an evaluation of the cardiovascular consequences of acute volume overload, and a better understanding of the intrahepatic vascular pressures driving gene delivery. Injection of DNA solution into the isolated segment of inferior vena cava (IVC) draining the hepatic veins is a potentially valuable low‐volume approach. Methods Various volumes of DNA solution (pGL3 plasmid) were injected at 100 ml/min either systemically or into the isolated IVC segment in the DA rat. Arterial pressure, portal venous pressure, heart rate and electrocardiogram, in addition to reporter gene expression in the liver, were monitored. Results The 2% volume was > 10 000‐fold more effective when delivered via the IVC segment than when given systemically, and as effective as 6% systemically. Isolation of the IVC segment caused profound falls in arterial pressure, with electrocardiogram signs of myocardial ischemia. On release of the IVC ties, without DNA infusion (no volume overload), arterial pressure recovered rapidly. However, with DNA infusion (volume overload) there was a brief recovery of arterial pressure, followed by complete heart block and fall in arterial pressure and pulse for several minutes. Portal venous pressure rose steeply to 30–33 mm Hg during the infusion. Conclusions The IVC segment approach enables excellent gene delivery to the whole liver with small volumes, but causes severe cardiovascular disturbances in the rat. Portal venous pressures are slightly higher than in the mouse, and suggest functional outflow obstruction by the capillary bed of the intestines. Copyright © 2008 John Wiley & Sons, Ltd.


  • Open Access

    Hydrodynamic gene delivery to the pig liver via an isolated segment of the inferior vena cava

    by J W Fabre, A Grehan, M Whitehorne, G J Sawyer, X Dong, S Salehi, L Eckley, X Zhang, M Seddon, A M Shah, et al.

    Hydrodynamic gene delivery is an attractive option for non-viral liver gene therapy, but requires evaluation of efficacy, safety and clinically applicable techniques in large animal models. We have evaluated retrograde delivery of DNA to the whole liver via the isolated segment of inferior vena cava (IVC) draining the hepatic veins. Pigs (18–20 kg weight) were given the pGL3 plasmid via two programmable syringe pumps in parallel. Volumes corresponding to 2% of body weight (360–400 ml) were delivered at 100 ml s−1 via a Y connector. The IVC segment pressure, portal venous pressure, arterial pressure, electrocardiogram (ECG) and pulse were monitored. Concurrent studies were performed in rats for interspecies comparisons. The hydrodynamic procedure generated intrahepatic vascular pressures of 101–126 mm Hg, which is ∼4 times higher than in rodents, but levels of gene delivery were ∼200-fold lower. Suprahepatic IVC clamping caused a fall in arterial pressure, with the development of ECG signs of myocardial ischaemia, but these abnormalities resolved rapidly. The IVC segment approach is a clinically acceptable approach to liver gene therapy. However, it is less effective in pigs than in rodents, possibly because of larger liver size or a less compliant connective tissue framework.